Arutla V - Search Results

1

Human NQO1 as a Selective Target for Anticancer Therapeutics and Tumor Imaging.

Khan AEMA, Arutla V, Srivenugopal KS. Khan AEMA, et al. Among authors: arutla v. Cells. 2024 Jul 29;13(15):1272. doi: 10.3390/cells13151272. Cells. 2024. PMID: 39120303 Free PMC article. Review.

2

Beyond the Diagnosis: A Deep Dive Into the End Stage Liver Disease Experience From the Patient Perspective.

Malik S, Arutla V, Alamin T, Warraich F, Syed TA, Nepal M, Ashraf MF, Dunnigan KJ. Malik S, et al. Among authors: arutla v. Am J Hosp Palliat Care. 2024 May 23:10499091241256629. doi: 10.1177/10499091241256629. Online ahead of print. Am J Hosp Palliat Care. 2024. PMID: 38780457

3

Application of a Specific and Sensitive NQO1 Turn-On Near-Infrared Fluorescence Probe for Live Cancer Cell and Xenografted Tumor Imaging in Nude Mice.

Srivenugopal KS, Arutla V, Punganuru SR, Khan AEMA. Srivenugopal KS, et al. Among authors: arutla v. Methods Mol Biol. 2024;2755:63-74. doi: 10.1007/978-1-0716-3633-6_4. Methods Mol Biol. 2024. PMID: 38319569

4

Genomic Space of MGMT in Human Glioma Revisited: Novel Motifs, Regulatory RNAs, NRF1, 2, and CTCF Involvement in Gene Expression.

Ibrahim Al-Obaide MA, Arutla V, Bacolod MD, Wang W, Zhang R, Srivenugopal KS. Ibrahim Al-Obaide MA, et al. Among authors: arutla v. Int J Mol Sci. 2021 Mar 2;22(5):2492. doi: 10.3390/ijms22052492. Int J Mol Sci. 2021. PMID: 33801310 Free PMC article.

5

Double-component diazeniumdiolate derivatives as anti-cancer agents.

Ji X, Chen Q, Arutla V, Khdour O, Hu QY, Chen S. Ji X, et al. Among authors: arutla v. Bioorg Med Chem. 2020 Apr 15;28(8):115405. doi: 10.1016/j.bmc.2020.115405. Epub 2020 Mar 3. Bioorg Med Chem. 2020. PMID: 32156499

6

Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.

Punganuru SR, Madala HR, Arutla V, Zhang R, Srivenugopal KS. Punganuru SR, et al. Among authors: arutla v. Sci Rep. 2019 Jun 12;9(1):8577. doi: 10.1038/s41598-019-44111-8. Sci Rep. 2019. PMID: 31189950 Free PMC article.

7

Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo.

Punganuru SR, Madala HR, Arutla V, Srivenugopal KS. Punganuru SR, et al. Among authors: arutla v. Cancers (Basel). 2018 Nov 28;10(12):470. doi: 10.3390/cancers10120470. Cancers (Basel). 2018. PMID: 30487423 Free PMC article.

8

Selective killing of human breast cancer cells by the styryl lactone (R)-goniothalamin is mediated by glutathione conjugation, induction of oxidative stress and marked reactivation of the R175H mutant p53 protein.

Punganuru SR, Madala HR, Arutla V, Srivenugopal KS. Punganuru SR, et al. Among authors: arutla v. Carcinogenesis. 2018 Dec 13;39(11):1399-1410. doi: 10.1093/carcin/bgy093. Carcinogenesis. 2018. PMID: 30010803

9

Conception, synthesis, and characterization of a rofecoxib-combretastatin hybrid drug with potent cyclooxygenase-2 (COX-2) inhibiting and microtubule disrupting activities in colon cancer cell culture and xenograft models.

Punganuru SR, Madala HR, Mikelis CM, Dixit A, Arutla V, Srivenugopal KS. Punganuru SR, et al. Among authors: arutla v. Oncotarget. 2018 May 25;9(40):26109-26129. doi: 10.18632/oncotarget.25450. eCollection 2018 May 25. Oncotarget. 2018. PMID: 29899846 Free PMC article.

10

Beyond Brooding on Oncometabolic Havoc in IDH-Mutant Gliomas and AML: Current and Future Therapeutic Strategies.

Madala HR, Punganuru SR, Arutla V, Misra S, Thomas TJ, Srivenugopal KS. Madala HR, et al. Among authors: arutla v. Cancers (Basel). 2018 Feb 11;10(2):49. doi: 10.3390/cancers10020049. Cancers (Basel). 2018. PMID: 29439493 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters